Patient presents with signs and symptoms consistent with thalassemia anemia.  Clinical presentation includes fatigue, weakness, shortness of breath, and pallor.  Physical examination may reveal splenomegaly.  The patient reports a family history of thalassemia, increasing the likelihood of a genetic predisposition to this inherited blood disorder.  Laboratory findings confirm the diagnosis of thalassemia, showing microcytic hypochromic anemia with reduced hemoglobin levels.  Peripheral blood smear demonstrates characteristic red blood cell abnormalities, including target cells and anisopoikilocytosis.  Hemoglobin electrophoresis or high-performance liquid chromatography (HPLC) is performed to determine the specific type of thalassemia (alpha-thalassemia or beta-thalassemia) and quantify the levels of different hemoglobin variants.  Iron studies, including serum iron, ferritin, and transferrin saturation, are conducted to differentiate thalassemia from iron deficiency anemia.  Genetic testing may be considered to confirm the diagnosis and identify the specific mutations involved.  Based on the severity of the anemia and the patient's clinical status, a treatment plan is developed.  Management options for thalassemia may include regular blood transfusions, iron chelation therapy to manage iron overload from transfusions, and folic acid supplementation to support red blood cell production.  Bone marrow transplantation may be considered in severe cases.  Patient education regarding the genetic basis of the disease, management strategies, and potential complications is provided.  Follow-up appointments are scheduled to monitor hemoglobin levels, assess treatment response, and manage potential complications such as iron overload, bone marrow expansion, and infections.  ICD-10 code D56 is assigned for thalassemia.  CPT codes for relevant laboratory tests and procedures, such as blood counts, hemoglobin electrophoresis, and iron studies, are also documented for medical billing and coding purposes.